Healionics Corporation provides biomaterial solutions to research institutions and medical device manufacturers seeking to enhance the biocompatibility and performance of current and next generation devices. Healionics has exclusive license to breakthrough technologies in biocompatibility created by University of Washington Engineered Biomaterials group (UWEB) over a 9-year period with $30M in funding as a US National Science Foundation Engineering Research Center (NSF ERC). Healionics' initial focus is to supply the innovative STAR material to qualified partners and customers.